MA
64
7
USB
55
-6
NEE
50
-5
MRK
25
-2
SNA
68
-2
HON
67
2
HST
49
-9
KEY
46
3
HCP
66
8
EOG
58
2
HP
48
3
TGT
22
2
GPC
40
3
HBI
59
4
ADSK
70
2
ROP
62
3
EL
25
4
MCD
52
2
EFX
38
2
WEC
53
-2
MA
64
7
USB
55
-6
NEE
50
-5
MRK
25
-2
SNA
68
-2
HON
67
2
HST
49
-9
KEY
46
3
HCP
66
8
EOG
58
2
HP
48
3
TGT
22
2
GPC
40
3
HBI
59
4
ADSK
70
2
ROP
62
3
EL
25
4
MCD
52
2
EFX
38
2
WEC
53
-2
Financhill
Back

RxSight Vs. Perspective Therapeutics Industry Stock Comparison

Sell
6

RXST
RxSight

Last Price:
44.85
Seasonality Move:
35.19%
Sell
30

CATX
Perspective Therapeutics

Last Price:
3.49
Seasonality Move:
34.33%
Sell
6
RxSight (RXST) is a Sell

Is RxSight a Buy, Sell or Hold?

  • The current RxSight [RXST] share price is $44.83. The Score for RXST is 6, which is 88% below its historic median score of 50, and infers higher risk than normal.
  • RXST is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
30
Perspective Therapeutics (CATX) is a Sell

Is Perspective Therapeutics a Buy, Sell or Hold?

  • The current Perspective Therapeutics [CATX] share price is $3.47. The Score for CATX is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
  • CATX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

RXST Stock Price Chart

What is RxSight's stock price today?

  • The RxSight share price today is $44.83
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RXST is experiencing slight selling pressure.

CATX Stock Price Chart

What is Perspective Therapeutics's stock price today?

  • The Perspective Therapeutics share price today is $3.47
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CATX is experiencing buying pressure, which is a positive indicator for future bullish movement.

RXST Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.59 Sell
Relative Strength Index (14 RSI): 37.28 Sell
Chaikin Money Flow: -218456 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (45.39 - 51.51) Sell
Bollinger Bands (100): (46.38 - 53.94) Sell

CATX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.06 Sell
Relative Strength Index (14 RSI): 14.31 Sell
Chaikin Money Flow: 5909257 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (7.39 - 12.93) Sell
Bollinger Bands (100): (10.25 - 14.79) Sell

RXST Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 44.79 Buy
20-day SMA: 48.1 Sell
50-day SMA: 49.48 Sell
200-day SMA: 52.75 Sell
8-day EMA: 45.39 Sell
20-day EMA: 47.07 Sell
50-day EMA: 48.99 Sell
200-day EMA: 48.78 Sell

CATX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 6.64 Sell
20-day SMA: 9.7 Sell
50-day SMA: 11.58 Sell
200-day SMA: 12.72 Sell
8-day EMA: 6.25 Sell
20-day EMA: 8.74 Sell
50-day EMA: 10.88 Sell
200-day EMA: 11.36 Sell

RxSight Earnings Growth & RXST Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.96 per share, and an increase next year of $0.29 per share.

Perspective Therapeutics Earnings Growth & CATX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.78 per share, and a decrease next year of $0.49 per share.

RxSight Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Perspective Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):